(Q43275120)

18 November 2017

title

Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease (English)

1 reference

18 November 2017

0 references

1 reference

Catherine M Greene

1

0 references

author name string

Teck Boon Low

series ordinal

2

1 reference

18 November 2017

Shane J O'Neill

series ordinal

3

1 reference

18 November 2017

Noel G McElvaney

series ordinal

4

1 reference

18 November 2017

language of work or name

English

0 references

publication date

17 September 2009

1 reference

American Journal of Respiratory and Critical Care Medicine

18 November 2017

published in

1 reference

18 November 2017

volume

181

1 reference

18 November 2017

issue

1

1 reference

18 November 2017

page(s)

31-35

1 reference

A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation

18 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0545OC

Matrix metalloproteinase-8 facilitates neutrophil migration through the corneal stromal matrix by collagen degradation and production of the chemotactic peptide Pro-Gly-Pro

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0545OC

Lung lavage fluid from patients with alpha 1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0545OC

Elastin fragments drive disease progression in a murine model of emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0545OC

Antielastin autoimmunity in tobacco smoking-induced emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0545OC

IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0545OC

IL-32, a proinflammatory cytokine in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0545OC

Range of antinuclear antibodies in "healthy" individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0545OC

Autoantibodies in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0545OC

Induction of lung emphysema is prevented by L-arginine-threonine-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0545OC

Interleukin-32 expression in the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0545OC

Autoantibodies to pancreatic hsp60 precede the development of glucose intolerance in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0545OC

Vasculitis and bronchiectasis in a patient with antibodies to bactericidal/permeability-increasing protein and alpha1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0545OC

Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0545OC

Detection of free antielastin antibodies among diabetic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0545OC

Anti-GAD65 reactive peripheral blood mononuclear cells in the pathogenesis of cystic fibrosis related diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200904-0545OC

10.1164/RCCM.200904-0545OC

21 January 2018

Identifiers

DOI

1 reference

18 November 2017

1 reference